The management report published by the pfm medical group today emphasises the role of innovation and internationalisation in driving forward the successful development of this mid-sized company. Non-domestic turnover was 17.3% up on the previous year and already constitutes 41.9% of the group’s total turnover. The greatest gains were achieved in North and South America, two particularly demanding markets.Strong growth occurred primarily in Cardiovascular Technology and Surgical Implants, both of which are newer, development-intensive areas. pfm medical is researching, producing and distributing new systems providing innovative therapeutic solutions in these and other areas. Investment in research and development by the group as a whole, already at a high level, was increased by a further 13.6% during the past year.In order to carry on supplying new answers to previously unanswered clinical questions, the company’s research and development efforts are clearly focused on forward-looking technology and on developing new manufacturing processes for internal production. The company’s own products already account for 41% of total turnover.The growth of the international concern, whose annual turnover has now reached 85 million euros, was greater than that of the parent company pfm medical ag. Here, too, the consistent strategy of diversification and internationalisation has proved its worth. CFO Reinhard Blunck feels that the company is also well prepared for the economic problems increasingly affecting south east Europe. In his view, “the spread of pfm medical’s activities across several different business areas, and the growing proportion made up by international business, strengthen the company with regard to changes in the situation in individual countries.”Alongside the economic dimension, long-term cooperative partnerships based on trust are a high priority for pfm medical. The company successfully maintains strategic alliances with leading international partner companies, a commitment highlighted in the management report. We can now look back on 40 years of close cooperation with FEATHER Safety Razor Co. Ltd. and Unomedical (a ConvaTec company), and on 20 years of trusting partnership with NuMED.
↧